Remifentanil and control bleeding during lumbar fusion surgery

Phase 2

• Conditions: Spinal fusion surgery.; Fusion with defective stereopsis; H53.32

• Registration Number: IRCT20200217046523N12
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Patient consent to participate in the study
Patient candidate for posterior spinal fusion surgery at levels 1 and 2
Not taking antihypertensive drugs

Exclusion Criteria

Changing the technique of operation and anesthesia for various reasons
Unwanted hemodynamic complications due to surgical technique
Severe cardiovascular disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Every 30 minutes during surgery and recovery. Method of measurement: Measured by the device.;Bleeding. Timepoint: Every 30 minutes during surgery and recovery. Method of measurement: Count the number of gases.